La Jolla Pharmaceutical Company
COMPOSITIONS AND METHODS FOR TREATING IRON OVERLOAD
Last updated:
Abstract:
The present disclosure relates to the use of hepcidin, mini-hepcidin, or a hepcidin analogue in therapeutic methods for the treatment and/or prevention of acquired iron overload or other conditions for which iron redistribution or sequestration is helpful.
Status:
Application
Type:
Utility
Filling date:
18 Jan 2018
Issue date:
7 Nov 2019